To see all protocols that comply with the WHO Essential Medicine List 

Stereotactic principles are based on accurate localisation, rigid immobilisation, and on-treatment verification. The delivery of ablative doses with minimal margin and steep dose gradients requires expert multidisciplinary involvement and technology. A team with adequate subspecialty training and experience in stereotactic radiosurgery is necessary to safely deliver this treatment. For more information about quality and safety considerations see the ASTRO white paper.r

The information contained in this protocol is based on the highest level of available evidence and consensus of the eviQ reference committee regarding their views of currently accepted approaches to treatment. Any clinician (medical oncologist, haematologist, radiation oncologist, medical physicist, radiation therapist, pharmacist or nurse) seeking to apply or consult this protocol is expected to use independent clinical judgement in the context of individual clinical circumstances to determine any patient's care or treatment. Use is subject to eviQ’s disclaimer available at

Send feedback for this page

First approved:
Last reviewed:
Review due:

The currency of this information is guaranteed only up until the date of printing, for any updates please check:

13 Apr 2021